22NW Fund, LP - 27 May 2025 SCHEDULE 13D/A Report for Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR)

Filing Manager: 22NW Fund, LP
Reporting Manager: 22NW Fund, LP
Security: Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share
Symbol: LFCR
Shares outstanding: 39.7M shares
Disclosed Ownership: 2.98M shares
Ownership: 7.49%
Form type: SCHEDULE 13D/A
Filing time: 29 May 2025, 21:56:36 UTC
Date of event: 27 May 2025
Previous filing: 26 Dec 2024
SEC: View on sec.gov

Reporting Managers (7)

Name	Ownership	Shares Owned	sole voting power	Signature	Title	CIK
22NW Fund, LP	7.49%	2.98M	2.98M	/s/ Aron R. English	Manager	0001640809
22NW, LP	7.49%	2.98M	2.98M	/s/ Aron R. English	President and Sole Shareholder	0001694297
22NW Fund GP, LLC	7.49%	2.98M	2.98M	/s/ Aron R. English	Manager	0001770575
22NW GP, Inc.	7.49%	2.98M	2.98M	/s/ Aron R. English	President and Sole Shareholder	0001783663
Aron R. English	7.49%	2.98M	2.98M	/s/ Aron R. English	Individually and as attorney-in-fact for Nathaniel Calloway	0001770436
Bryson O. Hirai-Hadley	0%	583	583	/s/ Bryson O. Hirai-Hadley	Bryson O. Hirai-Hadley	0001888106
Nathaniel Calloway	0%	0	0	/s/ Aron R. English	As attorney-in-fact for Nathaniel Calloway	0001952771